LANXESS: EBITDA pre exceptionals for the fourth quarter significantly above market expectation
Specialty chemicals company LANXESS expects to have achieved about EUR 159 million EBITDA pre exceptionals for the fourth quarter 2024. This significantly exceeds market expectation of currently EUR 130 million (VARA consensus) by 22 percent.
EBITDA pre exceptionals for the full year 2024 is therefore expected to amount to around EUR 614 million, approximately 20 percent above prior year’s level and at the upper end of the previously guided range of 10-20% growth.
The fourth quarter was positively influenced by a stronger than expected December, in particular due to customers’ pre-buying. This pull-forward effect occurred mainly in the U.S. for products of the segments Specialty Additives and Consumer Protection.
The underlying macroeconomic environment going into 2025 has however not improved.
The fiscal year 2024 will end with around EUR 2.4 billion net financial debt compared to EUR 2.5 billion at the end of 2023.
LANXESS will release its final results for the fourth quarter 2024 and the fiscal year 2024 on March 20, 2025. All figures provided in this release are preliminary and unaudited.
Cologne, 20 January 2025
Forward-Looking Statements
This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors, nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accepts any liability whatsoever arising directly or indirectly from the use of this document.
Information for editors:
All LANXESS news releases and their accompanying photos can be found at http://press.lanxess.com. Recent photos of the Board of Management and other LANXESS image material are available at http://photos.lanxess.com.
You can find further information concerning LANXESS chemistry at http://lanxess.com/en/Media/Stories.
